Regulatory Spine Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body byTim AllenFebruary 11, 2025
Financial Spine Top Stories Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded byJosh SandbergFebruary 4, 2025
Spine Top Stories Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference byJosh SandbergJanuary 31, 2025
Spine Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash byJosh SandbergNovember 21, 2024
Spine PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology byJosh SandbergSeptember 13, 2024
Spine Top Stories Aclarion Provides Corporate Update on Nociscan AI Technology Milestones byJosh SandbergSeptember 12, 2024
Spine Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial byJosh SandbergSeptember 10, 2024
Financial Spine Top Stories Aclarion Added to PRISM Emerging Medical Devices Index byJosh SandbergSeptember 6, 2024
Spine Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey byTim AllenAugust 29, 2024
Spine Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans byJosh SandbergAugust 21, 2024
